IL327395A - שימוש ב-alvelestat בחולים ספציפיים - Google Patents
שימוש ב-alvelestat בחולים ספציפייםInfo
- Publication number
- IL327395A IL327395A IL327395A IL32739526A IL327395A IL 327395 A IL327395 A IL 327395A IL 327395 A IL327395 A IL 327395A IL 32739526 A IL32739526 A IL 32739526A IL 327395 A IL327395 A IL 327395A
- Authority
- IL
- Israel
- Prior art keywords
- patient
- alvelestat
- disease
- salt
- sgrq
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202363613247P | 2023-12-21 | 2023-12-21 | |
| US202463559771P | 2024-02-29 | 2024-02-29 | |
| US202463682546P | 2024-08-13 | 2024-08-13 | |
| PCT/GB2024/053186 WO2025133628A1 (en) | 2023-12-21 | 2024-12-20 | Use of alvelestat in specific patients |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL327395A true IL327395A (he) | 2026-05-01 |
Family
ID=94227716
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL327395A IL327395A (he) | 2023-12-21 | 2024-12-20 | שימוש ב-alvelestat בחולים ספציפיים |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU2024406526A1 (he) |
| IL (1) | IL327395A (he) |
| WO (1) | WO2025133628A1 (he) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB202416580D0 (en) * | 2024-11-11 | 2024-12-25 | Mereo Biopharma 4 Ltd | New treatments |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0302486D0 (sv) | 2003-09-18 | 2003-09-18 | Astrazeneca Ab | Novel compounds |
| TW201036957A (en) | 2009-02-20 | 2010-10-16 | Astrazeneca Ab | Novel salt 628 |
| HUE064089T2 (hu) | 2020-04-16 | 2024-02-28 | Mereo Biopharma 4 Ltd | Alvelesztat neutrofil elasztáz inhibitort alkalmazó módszerek alfa-1-antitripszin hiány által közvetített légzõszervi megbetegedés kezelésére |
-
2024
- 2024-12-20 AU AU2024406526A patent/AU2024406526A1/en active Pending
- 2024-12-20 WO PCT/GB2024/053186 patent/WO2025133628A1/en active Pending
- 2024-12-20 IL IL327395A patent/IL327395A/he unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2024406526A1 (en) | 2026-04-16 |
| WO2025133628A1 (en) | 2025-06-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL297849B1 (he) | הרכב לשימוש בטיפול במחלה הקשורה ל- apol1 | |
| GB202108572D0 (en) | Therapeutic compounds and their use | |
| GB202014736D0 (en) | Novel compounds and their use in therapy | |
| GB202019475D0 (en) | Therapeutic compounds and their use | |
| GB202302767D0 (en) | Improvements in or relating to patient care | |
| IL285171B2 (he) | טיפול בנגעי עור וגרד בחולי prurigo nodularis | |
| IL277480A (he) | שימוש בקלציפדיול במטופלי כירורגיה בריאטרית | |
| IL314984A (he) | Pclx-001 אוראלי לטיפול בסרטן אנושי | |
| EP4193995A4 (en) | USE OF BTK INHIBITORS TO TREAT DISEASES | |
| IL316558A (he) | שימוש רפואי חדש של תפוקסיפארין | |
| GB202205895D0 (en) | New medical uses | |
| IL319234A (he) | תרכובות פירזולילסולפונאמיד והשימוש שלהן בתרפיה | |
| GB202403391D0 (en) | Novel compounds and their use in therapy | |
| CA3305988A1 (en) | Use of alvelestat in specific patients | |
| GB202509498D0 (en) | Medical use | |
| GB202509499D0 (en) | Medical use | |
| GB202509495D0 (en) | Medical use | |
| GB202305541D0 (en) | Novel compounds and their use in therapy | |
| GB202305546D0 (en) | Novel compounds and their use in therapy | |
| GB202504572D0 (en) | New medical use | |
| GB202217810D0 (en) | Medical use | |
| GB202216910D0 (en) | Medical use | |
| GB202508498D0 (en) | Compounds and their therapeutic use | |
| GB202314100D0 (en) | New medical use | |
| GB202302278D0 (en) | New medical use |